Miscellaneous Metabolic Disorders
Gene: ALDH5A1
Inborn error of gamma-aminobutyric acid metabolism. Well-established gene-disease association (see OMIM entry).
Sources: NHS GMSCreated: 25 Jan 2021, 12:28 a.m.
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Succinic semialdehyde dehydrogenase deficiency MIM#271980; disorder of neurotransmitter metabolism
Publications
Variants in this GENE are reported as part of current diagnostic practice
Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare autosomal recessive neurologic disorder in which an enzyme defect in the GABA degradation pathway causes a consecutive elevation of gamma-hydroxybutyric acid (GHB) and GABA. The clinical features include developmental delay, hypotonia, mental retardation, ataxia, seizures, hyperkinetic behavior, aggression, and sleep disturbances. Over 50 unrelated families reported.Created: 23 Aug 2020, 2:51 a.m. | Last Modified: 23 Aug 2020, 2:51 a.m.
Panel Version: 0.3876
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Succinic semialdehyde dehydrogenase deficiency, MIM# 271980
Publications
Gene: aldh5a1 has been classified as Green List (High Evidence).
Gene: aldh5a1 has been classified as Green List (High Evidence).
gene: ALDH5A1 was added gene: ALDH5A1 was added to Miscellaneous Metabolic Disorders. Sources: NHS GMS Mode of inheritance for gene: ALDH5A1 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: ALDH5A1 were set to 9683595; 14635103; 32887777 Phenotypes for gene: ALDH5A1 were set to Succinic semialdehyde dehydrogenase deficiency MIM#271980; disorder of neurotransmitter metabolism Review for gene: ALDH5A1 was set to GREEN gene: ALDH5A1 was marked as current diagnostic